Sarah Anand is a Hematology physician affiliated with University of Michigan. OpenAlex indexes 62 publications with 1,658 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1500 E Medical Center Dr
Ann Arbor, MI 481095000
Telephone
734-936-4000Provider last certified this registry record 21 Feb 2020.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- CSL BehringProgram year20242 payments
- CSL BehringProgram year20238 payments
- CSL BehringProgram year20223 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
34.8%Short-acting sulfonamides19%Sulfamethoxazole-Trimethoprim100%Part D≥12 patientsAzole Antifungal15.8%Posaconazole100%Part D<11 patientsCancer & immunology
28.5%Kinase inhibitor22.2%Jakafi100%Part D≥11 patientsCalcineurin inhibitor6.3%Restasis100%Part D<11 patientsMetabolism & gastrointestinal
21.7%Bile Acid9.5%Ursodiol100%Part D<11 patientsProton pump inhibitor6.3%Omeprazole100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of Non-Compliance with NIH Consensus Guidelines for PFT Performance in Allogeneic Hematopoietic Cell Transplant Recipients.
Biology of Blood and Marrow Transplantation
2026 - NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025
Journal of the National Comprehensive Cancer Network
2025 - Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>
Journal of Clinical Oncology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Moshe Talpaz, MD
University of Michigan
William Herman, MD
University of Michigan
Max Wicha, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”